SMOKE study.
Completed
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 234
Inclusion Criteria
1. Outpatients of Medisch Spectrum Twente (Enschede), Slotervaart hospital (Amsterdam), or Catharina hospital (Eindhoven);
2. Current smoker;
Exclusion Criteria
1. Hypersensitivity for elements of Bupropion SR;
2. (Past history of) serious psychiatric co-morbidity;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemically validated (salivary cotinine) continuous abstinence rate (defined as validated abstinence at six months and twelve months after the start of the intervention); biochemically validated point prevalence abstinence rate at 12 months after the start of SmokeStopTherapy (point prevalence).
- Secondary Outcome Measures
Name Time Method